Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADx-Underserved Populations (RADxUP) Phase III

NCT07074171 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT07074171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07074171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADx-Underserved Populations (RADxUP) Phase III
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2023
Completion date
December 12, 2024
Enrollment
384 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 testing behaviors